Similar Items: Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis
- Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis
- Real-World Experience of Sustained-Release Fampridine in Chinese Patients With Multiple Sclerosis: A Case Series on Walking Impairment and Fatigue
- Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China
- Real‐world effectiveness of cenobamate in drug‐resistant and ultra‐refractory epilepsy: A multicenter study
- Social Cognition in Multiple Sclerosis: A Multidomain Investigation
- Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom